Rare diseases are rare, but
rare disease patients are numerous

Caption : Recruiting trial = ; Ongoing trial =

• • GERMANY
  • Berlin
  • NOT YET IDENTIFIED - DE
  • 
  • A Multicentre, single arm, observational phase IV study to assess the safety and efficacy of Nelarabine in children and young adults (up to 21 Years of Age) with relapsed or refractory T-Acute Lymphoblastic Leukaemia (T-ALL) or T-Lymphoblastic Lymphoma (T-LBL) - DE
  • Not yet identified - DE
  • More details
• • SPAIN
  • Madrid
  • NOT YET IDENTIFIED - ES
  • 
  • A Multicentre, Single Arm, Observational Phase IV Study to Assess the Safety and Efficacy of Nelarabine in Children and Young Adults (up to 21 Years of Age) With Relapsed or Refractory T-lineage Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma
  • Not yet identified - ES
  • More details